282 related articles for article (PubMed ID: 24176397)
21. Design, synthesis and biological evaluation of novel potent STAT3 inhibitors based on BBI608 for cancer therapy.
Feng KR; Wang F; Shi XW; Tan YX; Zhao JY; Zhang JW; Li QH; Lin GQ; Gao D; Tian P
Eur J Med Chem; 2020 Sep; 201():112428. PubMed ID: 32603980
[TBL] [Abstract][Full Text] [Related]
22. Synthesis of novel bis-anthraquinone derivatives and their biological evaluation as antitumor agents.
Taher AT; Hegazy GH
Arch Pharm Res; 2013 May; 36(5):573-8. PubMed ID: 23471561
[TBL] [Abstract][Full Text] [Related]
23. Comparison of the cytotoxic activities of naturally occurring hydroxyanthraquinones and hydroxynaphthoquinones.
Cui XR; Tsukada M; Suzuki N; Shimamura T; Gao L; Koyanagi J; Komada F; Saito S
Eur J Med Chem; 2008 Jun; 43(6):1206-15. PubMed ID: 17949858
[TBL] [Abstract][Full Text] [Related]
24. Small molecules, LLL12 and FLLL32, inhibit STAT3 and exhibit potent growth suppressive activity in osteosarcoma cells and tumor growth in mice.
Onimoe GI; Liu A; Lin L; Wei CC; Schwartz EB; Bhasin D; Li C; Fuchs JR; Li PK; Houghton P; Termuhlen A; Gross T; Lin J
Invest New Drugs; 2012 Jun; 30(3):916-26. PubMed ID: 21340507
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and biological evaluation of new cytotoxic azanaphthoquinone pyrrolo-annelated derivatives.
Shanab K; Schirmer E; Knafl H; Wulz E; Holzer W; Spreitzer H; Schmidt P; Aicher B; Müller G; Günther E
Bioorg Med Chem Lett; 2010 Jul; 20(13):3950-2. PubMed ID: 20537894
[TBL] [Abstract][Full Text] [Related]
26. A small molecule, LLL12 inhibits constitutive STAT3 and IL-6-induced STAT3 signaling and exhibits potent growth suppressive activity in human multiple myeloma cells.
Lin L; Benson DM; DeAngelis S; Bakan CE; Li PK; Li C; Lin J
Int J Cancer; 2012 Mar; 130(6):1459-69. PubMed ID: 21520044
[TBL] [Abstract][Full Text] [Related]
27. Design, synthesis and activity of BBI608 derivatives targeting on stem cells.
Zhou Q; Peng C; Du F; Zhou L; Shi Y; Du Y; Liu D; Sun W; Zhang M; Chen G
Eur J Med Chem; 2018 May; 151():39-50. PubMed ID: 29604543
[TBL] [Abstract][Full Text] [Related]
28. Naphthoquinones, anthraquinones and naphthalene derivatives from the bulbs of Eleutherine americana.
Mahabusarakam W; Hemtasin C; Chakthong S; Voravuthikunchai SP; Olawumi IB
Planta Med; 2010 Mar; 76(4):345-9. PubMed ID: 19777423
[TBL] [Abstract][Full Text] [Related]
29. Synthesis, human telomerase inhibition and anti-proliferative studies of a series of 2,7-bis-substituted amido-anthraquinone derivatives.
Huang HS; Huang KF; Li CL; Huang YY; Chiang YH; Huang FC; Lin JJ
Bioorg Med Chem; 2008 Jul; 16(14):6976-86. PubMed ID: 18571928
[TBL] [Abstract][Full Text] [Related]
30. Naphthohydroquinones, naphthoquinones, anthraquinones, and a naphthohydroquinone dimer isolated from the aerial parts of Morinda parvifolia and their cytotoxic effects through up-regulation of p53.
Kang J; Zhang P; Gao Z; Zhang J; Yan Z; Wang H; Chen R
Phytochemistry; 2016 Oct; 130():144-51. PubMed ID: 27298278
[TBL] [Abstract][Full Text] [Related]
31. Cytotoxic Naphthoquinone and Azaanthraquinone Derivatives from an Endophytic Fusarium solani.
Chowdhury NS; Sohrab MH; Rana MS; Hasan CM; Jamshidi S; Rahman KM
J Nat Prod; 2017 Apr; 80(4):1173-1177. PubMed ID: 28257197
[TBL] [Abstract][Full Text] [Related]
32. Novel rhein analogues as potential anticancer agents.
Yang X; Sun G; Yang C; Wang B
ChemMedChem; 2011 Dec; 6(12):2294-301. PubMed ID: 21954017
[TBL] [Abstract][Full Text] [Related]
33. A novel non-phosphorylated potential antitumoral peptide inhibits STAT3 biological activity.
Dourlat J; Liu WQ; Sancier F; Edmonds T; Pamonsinlapatham P; Cruzalegui F; Garbay C
Biochimie; 2009 Aug; 91(8):996-1002. PubMed ID: 19470402
[TBL] [Abstract][Full Text] [Related]
34. Design of antineoplastic agents based on the "2-phenylnaphthalene-type" structural pattern. 4. Synthesis and biological activity of 2-chloro-3-(substituted phenoxy)-1, 4-naphthoquinones and related 5,8-dihydroxy-1,4-naphthoquinones.
Chang HX; Chou TC; Savaraj N; Liu LF; Yu C; Cheng CC
J Med Chem; 1999 Feb; 42(3):405-8. PubMed ID: 9986711
[TBL] [Abstract][Full Text] [Related]
35. Anthraquinone, cyclopentanone, and naphthoquinone derivatives from the sea fan-derived fungi Fusarium spp. PSU-F14 and PSU-F135.
Trisuwan K; Khamthong N; Rukachaisirikul V; Phongpaichit S; Preedanon S; Sakayaroj J
J Nat Prod; 2010 Sep; 73(9):1507-11. PubMed ID: 20815366
[TBL] [Abstract][Full Text] [Related]
36. QSAR on antiproliferative naphthoquinones based on a conformation-independent approach.
Duchowicz PR; Bennardi DO; Bacelo DE; Bonifazi EL; Rios-Luci C; Padrón JM; Burton G; Misico RI
Eur J Med Chem; 2014 Apr; 77():176-84. PubMed ID: 24631897
[TBL] [Abstract][Full Text] [Related]
37. Discovery of novel STAT3 small molecule inhibitors via in silico site-directed fragment-based drug design.
Yu W; Xiao H; Lin J; Li C
J Med Chem; 2013 Jun; 56(11):4402-12. PubMed ID: 23651330
[TBL] [Abstract][Full Text] [Related]
38. Synthesis, telomerase evaluation and anti-proliferative studies on various series of diaminoanthraquinone-linked aminoacyl residue derivatives.
Huang FC; Huang KF; Chen RH; Wu JE; Chen TC; Chen CL; Lee CC; Chen JY; Lin JJ; Huang HS
Arch Pharm (Weinheim); 2012 Feb; 345(2):101-11. PubMed ID: 21956661
[TBL] [Abstract][Full Text] [Related]
39. Pyranonaphthoquinone and anthraquinone derivatives from Ventilago harmandiana and their potent anti-inflammatory activity.
Panthong K; Hongthong S; Kuhakarn C; Piyachaturawat P; Suksen K; Panthong A; Chiranthanut N; Kongsaeree P; Prabpai S; Nuntasaen N; Reutrakul V
Phytochemistry; 2020 Jan; 169():112182. PubMed ID: 31669820
[TBL] [Abstract][Full Text] [Related]
40. LLL-3, a STAT3 inhibitor, represses BCR-ABL-positive cell proliferation, activates apoptosis and improves the effects of Imatinib mesylate.
Mencalha AL; Du Rocher B; Salles D; Binato R; Abdelhay E
Cancer Chemother Pharmacol; 2010 May; 65(6):1039-46. PubMed ID: 19701750
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
